Vijaya Diagnostic Centre share price
You have to be logged in to add this to Watchlist.- ₹983.85(-1.17%)February 13, 2026 15:29:00 PM IST
- NSE
- BSE
- Vol : 171.78 K (NSE + BSE)Last 20 day avg : 124.54 K
Vijaya Diagnostic Centre is trading -1.17% lower at Rs 983.85 as compared to its last closing price. Vijaya Diagnostic Centre has been trading in the price range of 1,012.90 & 975.25. Vijaya Diagnostic Centre has given -6.26% in this year & 2.38% in the last 5 days. Vijaya Diagnostic Centre has TTM P/E ratio 67.77 as compared to the sector P/E of 30.79.There are 8 analysts who have initiated coverage on Vijaya Diagnostic Centre. There are 3 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 43.28 Crores in its last quarter.Listed peers of Vijaya Diagnostic Centre include Max Healthcare Institute (-0.87%), Global Health (-0.89%), Apollo Hospitals Enterprise (-0.31%).The Mutual Fund holding in Vijaya Diagnostic Centre was at 27.98% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Vijaya Diagnostic Centre was at 15.10% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 14, 2026, 10:06 AM UTC
- BetaLow volatility0.45Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.40The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.20Annual dividends as a percentage of the stock price.
- P/BLower than historical values12.83The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values67.47Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation7.34The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Max Healthcare Institute | Neutral | 1,053.65 | -0.87 | 1,02,529.92 | 93.43 | 11.21 | 0.14 | 29.50 |
| Global Health | Neutral | 1,136.55 | -0.89 | 30,436.57 | 61.73 | 9.45 | 0.04 | 18.41 |
| Apollo Hospitals Enterprise | Bullish | 7,514.15 | -0.31 | 1,07,986.07 | 71.09 | 12.56 | 0.26 | 83.18 |
| Fortis Healthcare | Bullish | 916.10 | -1.30 | 68,953.72 | 80.04 | 7.64 | 0.11 | 25.92 |
| Narayana Hrudayalaya | Neutral | 1,826.60 | -2.00 | 37,226.68 | 47.66 | 10.51 | 0.24 | 59.03 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-13 | Quarterly Results |
| 2025-11-04 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results & Others |
- IndustryHealthcare Facilities
- ISININE043W01024
- BSE Code543350
- NSE CodeVIJAYA
Vijaya Diagnostic Centre is trading at 983.85 as on Fri Feb 13 2026 09:59:00. This is -1.17% lower as compared to its previous closing price of 995.45.
The market capitalization of Vijaya Diagnostic Centre is 10141.74 Cr as on Fri Feb 13 2026 09:59:00.
The average broker rating on Vijaya Diagnostic Centre is Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 2 analysts have given a buy rating
- 2 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Vijaya Diagnostic Centre is 1179.55 whereas the 52 wk low is 800.00
Vijaya Diagnostic Centre can be analyzed on the following key metrics -
- TTM P/E: 67.77
- Sector P/E: 30.79
- Dividend Yield: 0.20%
- D/E ratio: 0.42
Vijaya Diagnostic Centre reported a net profit of 143.08 Cr in 2025.
The Mutual Fund Shareholding was 27.98% at the end of 31 Dec 2025.